(Q28343462)

English

Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group

scientific article

In more languages

Statements

scholarly article

0 references

Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

H Ueoka

1

0 references

M Tanimoto

2

0 references

K Kiura

3

0 references

M Tabata

4

0 references

N Takigawa

5

0 references

Y Segawa

6

0 references

I Takata

7

0 references

K Eguchi

8

0 references

N Okimoto

9

0 references

S Harita

10

0 references

H Kamei

11

0 references

T Shibayama

12

0 references

Y Watanabe

13

0 references

S Hiraki

14

0 references

M Harada

15

0 references

language of work or name

0 references

publication date

6 July 2001

0 references

British Journal of Cancer

0 references

85

0 references

1

0 references

9-13

0 references

copyright license

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

1 July 2001

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363923

7 April 2017

Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363923

29 September 2017

Evolution of cisplatin-based chemotherapy in non-small cell lung cancer: a historical perspective and the eastern cooperative oncology group experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363923

29 September 2017

Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363923

29 September 2017

Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363923

29 September 2017

A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363923

29 September 2017

New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363923

29 September 2017

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363923

29 September 2017

Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363923

2 June 2018

Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363923

2 June 2018

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.

1 reference

https://api.crossref.org/works/10.1054%2FBJOC.2001.1861

21 January 2018

Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenografts.

1 reference

https://api.crossref.org/works/10.1054%2FBJOC.2001.1861

21 January 2018

Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan (CPT-11) in combination with weekly administration of cisplatin (CDDP) for non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11437395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1054/BJOC.2001.1861

0 references

Dimensions Publication ID

0 references

release_y7elfgffzzb3hpc5bev6ubp7di

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28343462&oldid=2175245327"